In addition, both Braf and Nras mutations also occur in benign naevi and seem insufficient to cause progression towards melanoma (10), altogether suggesting that Rac1P29S could also be a driving event independently of these oncogenes (11). This evidence concerns the gene NRAS and melanoma.